Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2021-11-19 Report Publication Anno…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
PUBLICATION OF OFFERING CIRCULAR-YANCOAL INTERNATIONAL RESOURCES DEVELOPMENT CO., LIMITED-U.S.$300,000,000 2.90% GUARANTEED BONDS DUE 2024
Report Publication Announcement Classification · 95% confidence The document is an announcement published on the Hong Kong Stock Exchange regarding the publication of an Offering Memorandum for a bond issuance by Yancoal International Resources Development Co., Limited. It includes disclaimers about the nature of the offering, regulatory compliance, and distribution restrictions. The text explicitly states that the Offering Memorandum is appended to the announcement and is for information purposes only, not constituting an offer to sell securities. The document is lengthy (15,000 characters) but primarily serves as a publication announcement of the Offering Memorandum rather than the memorandum itself or a detailed financial report. Therefore, it fits the category of a Report Publication Announcement (RPA) rather than a Capital/Financing Update (CAP) or other categories related to financial results or management information.
2021-11-19 English
NOTICE OF LISTING ON THE STOCK EXCHANGE OF HONG KONG LIMITED-YANCOAL INTERNATIONAL RESOURCES DEVELOPMENT CO., LIMITED-US$300,000,000 2.90% Senior Guaranteed Bonds due 2024
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the listing of bonds on the Stock Exchange of Hong Kong. It includes details about the bond issue, the listing application, and the expected effective date of listing. The text explicitly states it is an announcement and does not contain financial statements or detailed financial data. The document length is relatively short (3544 characters) and serves as a notice rather than a full report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about a capital market transaction but not a full Capital/Financing Update report, which would typically include more detailed financial or transaction data.
2021-11-18 English
CONNECTED TRANSACTION-ACQUISITION OF 62% EQUITY INTEREST IN YULIN LOGISTICS COMPANY
Capital/Financing Update Classification · 95% confidence The document is an announcement by Yanzhou Coal Mining Company Limited regarding the acquisition of a 62% equity interest in Yulin Logistics Company. It details the transaction terms, parties involved, consideration, and regulatory implications under the Listing Rules. The content focuses on a connected transaction acquisition, including background, financial information of the acquired company, and board approval details. There are no financial statements or comprehensive financial performance data typical of annual or interim reports. The document is a formal announcement of a corporate transaction rather than a full report or presentation. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as acquisitions.
2021-11-16 English
ANNOUNCEMENT ON THE PARTICIPATION IN 2021 ONLINE COLLECTIVE RECEPTION ACTIVITY FOR INVESTORS
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an online collective reception activity for investors. It describes the event details, participants, and how investors can join. There is no financial data, no report attached or referenced as being published, and no detailed financial or management information. The document is short (2917 characters) and serves as a notification of an investor engagement event rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a proxy solicitation, voting result, or board change announcement. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-11-14 English
VOLUNTARY ANNOUNCEMENT - CSTONE AND DOTBIO HAVE SIGNED A GLOBAL DISCOVERY COLLABORATION AND OPTION AGREEMENT TO EXPAND EMERGING PORTFOLIO OF NEXT-GENERATION INNOVATIVE THERAPEUTICS
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by CStone Pharmaceuticals about a new global discovery collaboration and option agreement with DotBio. It details the nature of the collaboration, strategic goals, and company background. There are no financial statements, regulatory filings, voting results, or management changes. The content focuses on a partnership and R&D strategy update rather than financial results or governance. The document length is 8476 characters, which is substantial but the content is clearly an announcement of a collaboration agreement rather than a financial report or regulatory filing. Therefore, the best fitting category is a general Regulatory Filing (RNS) as it is a miscellaneous announcement that does not fit other specific categories like M&A, earnings, or management changes.
2021-11-09 English
Notification Letter
Report Publication Announcement Classification · 100% confidence The document is a notification letter from Yanzhou Coal Mining Company Limited dated 8 November 2021. It informs shareholders about the publication of corporate communications related to the 2021 Third Extraordinary General Meeting, including a circular, notice, and proxy form. The letter provides instructions on how shareholders can access these documents online or request printed copies, and includes a change request form for shareholders to update their preferences for receiving future corporate communications. The document does not contain any financial statements, detailed financial analysis, or substantive financial data. It is primarily an announcement about the availability and distribution of corporate communications rather than the communications themselves. Therefore, it fits the definition of a Report Publication Announcement (RPA), which is an announcement regarding the timing, release, or publication of company reports or communications.
2021-11-08 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.